Related Experiment Videos
Pediatric patients. Tolerance levels and effects of treatment
1Department of Radiation Oncology, Stanford University Medical Center, Calif.
Frontiers of Radiation Therapy and Oncology
|January 1, 1989
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Stable transformation and regeneration of transgenic plants of Pinus radiata D. Don.
Plant cell reports·2019
Histologic subtypes of breast cancer following radiotherapy for Hodgkin lymphoma.
Annals of oncology : official journal of the European Society for Medical Oncology·2014
Proton therapy in the clinic.
Frontiers of radiation therapy and oncology·2011
Proton therapy: clinical gains through current and future treatment programs.
Frontiers of radiation therapy and oncology·2011
Stereotactic body radiotherapy for prostate cancer: current results of a phase II trial.
Frontiers of radiation therapy and oncology·2011
Stereotactic body radiation therapy for gastrointestinal malignancies.
Frontiers of radiation therapy and oncology·2011
Stereotactic body radiation therapy for thoracic cancers: recommendations for patient selection, setup and therapy.
Frontiers of radiation therapy and oncology·2011
Stereotactic body radiation therapy: normal tissue and tumor control effects with large dose per fraction.
Frontiers of radiation therapy and oncology·2011
[Masked pediatric pathological femoral fracture : Case report of a sarcoma-associated femoral fracture after adequate trauma].
Unfallchirurgie (Heidelberg, Germany)·2026
Novel SLC6A9 variants in an adult presenting with GlyT1 encephalopathy.
Journal of human genetics·2026
Severe Phenotype in an Indian Family With Progressive Pseudorheumatoid Arthropathy of Childhood.
American journal of medical genetics. Part A·2026
Bridging pediatric and adult neuro-oncology: Insights into adolescents and young adults (AYA) central nervous system tumors.
Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics·2026